Author:
García-Sanz R,González-Porras J R,Hernández J M,Polo-Zarzuela M,Sureda A,Barrenetxea C,Palomera L,López R,Grande-García C,Alegre A,Vargas-Pabón M,Gutiérrez O N,Rodríguez J A,San Miguel J F
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference54 articles.
1. San Miguel JF, Bladé CJ, García-Sanz R . Treatment of multiple myeloma. Haematologica 1999; 84: 36–58.
2. Attal M, Harousseau J-L, Stoppa A-M, Sotto JJ, Fuzibet JG, Rossi JF et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. N Engl J Med 1996; 335: 91–97.
3. Tricot G, Jagannath S, Vesole DH, Crowley J, Barlogie B . Relapse of multiple myeloma after autologous transplantation: survival after salvage therapy. Bone Marrow Transplant 1995; 16: 7–11.
4. Vesole DH, Barlogie B, Jagannath S, Cheson B, Tricot G, Alexanian R et al. High-dose therapy for refractory multiple myeloma: improved prognosis with better supportive care and double transplants. Blood 1994; 84: 950–956.
5. Parameswaran R, Giles C, Boots M, Littlewood TJ, Mills MJ, Kelsey SM et al. CCNU (lomustine), idarubicin and dexamethasone (CIDEX): an effective oral regimen for the treatment of refractory or relapsed myeloma. Br J Haematol 2000; 109: 571–575.
Cited by
130 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献